No. 23A565

Liquidia Technologies, Inc. v. United Therapeutics Corporation

Lower Court: Federal Circuit
Docketed: 2023-12-19
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: administrative-preclusion biotechnology-patents inter-partes-review issue-estoppel patent-infringement patent-validity
Key Terms:
TradeSecret Patent
Latest Conference: N/A
Question Presented (AI Summary)

Whether a Patent Trial and Appeal Board (PTAB) decision finding patent claims unpatentable can serve as a defense to induced patent infringement before the administrative decision becomes final on appeal

Question Presented (OCR Extract)

No question identified. :

Docket Entries

2023-12-20
Application (23A565) granted by The Chief Justice extending the time to file until January 24, 2024.
2023-12-15
Application (23A565) to extend the time to file a petition for a writ of certiorari from December 25, 2023 to January 24, 2024, submitted to The Chief Justice.
Main DocumentProof of ServiceMain DocumentProof of Service

Attorneys

Liquidia Technologies Inc.
Kathleen Roberta Hartnett — Cooley LLP, Petitioner
Kathleen Roberta Hartnett — Cooley LLP, Petitioner